Malignant hyperthermia

Morris, David
February 2011
Independent Nurse;2/21/2011, p23
The article offers information on malignant hyperthermia (MH), a rare condition that occurs following the use of general anaesthetic (GA) agents. It outlines the clinical features of MH, including increasing muscle tone that leads to rigidity, tachycardia, hypertension, sweating and skin mottling. The steps involved in managing an MH crisis are presented, including the use of alternate anaesthetic agents and the administration of oxygen in clean circuit.


Related Articles

  • Sindrome da Ipertermia Maligna: una revisione bibliograica. SONIA, POLIN; DORIGO, MARA; CORSO, MARILISA // SCENARIO: Official Italian Journal of ANIARTI;2014, Vol. 31 Issue 4, p5 

    No abstract available.

  • Malignant Hyperthermia Susceptibility and the Trauma Patient. Sheehan, Jacqueline A. // Military Medicine;Jun2005, Vol. 170 Issue 6, p510 

    Assorted casualties are expected from combat. Triage of the wounded may result in some going directly to surgery. Although every minute is essential, anesthetic care of these trauma patients must adhere to all established standards of care. A timely preoperative assessment must include...

  • Renal Transplantation from an Unrelated Living Donor to a Malignant Hyperthermia-Susceptible Patient: A Case Report. Kern, Marli // AANA Journal;Oct2011, Vol. 79 Issue 5, p397 

    A 56-year-old patient with renal insufficiency secondary to Alport syndrome presented for kidney transplantation from an unrelated living donor. The recipient had a medical history that included 2 episodes of malignant hyperthermia: in 1989 and 1991. On both occasions she was treated with...

  • Malignant Hyperthermia: A Pharmacogenetic Disease of Ca++Regulating Proteins. Nelson, Thomas E. // Current Molecular Medicine;Jun2002, Vol. 2 Issue 4, p347 

    Malignant hyperthermia (MH) is a pharmacogenetic, life-threatening hypermetabolic syndrome in genetically predisposed individuals exposed to certain anesthetic agents. Discovered by Denborough and Lovell [1] in 1960, MH was associated with high mortality and morbidity as the cause was unknown...

  • Isoflurane.  // Reactions Weekly;1/12/2008, Issue 1184, p24 

    The article describes the case of a liver transplant recipient, who developed malignant hyperthermia while receiving isoflurane during transplantation. The patient was treated with dantrolene, which caused hepatic graft dysfunction. Investigations showed that the patient's mother had died under...

  • Malignant Hyperthermia during Desflurane - Succinylcholine Anesthesia for Neurosurgery: A case report. Baysal, Zeynep; Avci, Emel; Torun, Fuat; Cengiz, Mustafa; Çigdem, Ali; Togrul, Turhan; Nacar, Halil; Çakir, Ahmet // Internet Journal of Neurosurgery;2009, Vol. 5 Issue 2, p6 

    Desflurane has been known as a weak triggering anesthetic of malignant hyperthermia (MH). It may produce a delayed onset of symptoms. In addition the use of succinylcholine may aggravate occurrence of MH. The prolonged interval after exposure may occur more than 3 h after the induction of...

  • Malignant hyperthermia resolving with discontinuation of sevoflurane alone. Abolkhair, Abdullah; Seefelder, Christian // Saudi Journal of Anaesthesia;Apr2011, Vol. 5 Issue 2, p229 

    An otherwise healthy 13 year old developed hypercarbia and increased temperature during anesthesia with sevoflurane. Discontinuation of sevoflurane, surface cooling, and hyperventilation resulted in prompt resolution. However, hyperkalemia continued to raise the suspicion for malignant...

  • Malignant hypothermia: considerations for the general surgeon. Heggie, Jane E. // Canadian Journal of Surgery;Oct2002, Vol. 45 Issue 5, p369 

    Focuses on the diagnosis and management of acute malignant hyperthermia in North America. Characterization of hyperthermia; Use of inhalational vapors in anesthesia; Importance of molecular genetics in identifying genetic markers.

  • Babies in Distress. Nnamani, Nwamaka Pamela; Moss, David R. // Clinical Pediatrics;Jun2015, Vol. 54 Issue 6, p557 

    There has been international debate on the infrequent occurrence of malignant hyperthermia in infants, where some reports state that this phenomenon does not exist in this age group; but the vast majority of studies counteract this argument. The proportion of documented cases in the infant...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics